Which of the Following Should Not Be Considered a Benefit

question 81

Multiple Choice

Which of the following should not be considered a benefit to a firm that is issuing an IPO?

• A) access to additional capital
• B) provide an alternative to cash for future acquisitions
• C) have another source, other than cash for executive compensation
• D) limits the founder's ownership dilution

---

Definitions:

Cholecystokinin

A hormone that stimulates the digestion of fat and protein by releasing bile from the gallbladder and digestive enzymes from the pancreas.

Peptide Hormone

Hormones composed of short chains of amino acids that are involved in regulating physiological and biochemical processes in the body.

Satiation

The feeling of fullness and satisfaction that signals the end of an eating occasion, leading to the cessation of food intake.

Low Leptin

A condition characterized by reduced levels of leptin, a hormone that regulates hunger and energy expenditure.